SLC7A11 and renal cell carcinoma: Further, SLC7A11, which forms a heterodimer with SLC3A2 and is known as a xCT (cystine/glutamate antiporter), has higher expression in RCC than in the non-neoplastic kidney and has been shown to be related to a worse prognosis in RCC [43].